Does GLP-1 cause hair loss?
Direct answer
What you need to know
Evidence strength: ModerateUsually indirectly, yes — but the medication is not attacking your hair. Shedding during GLP-1 treatment is almost always telogen effluvium: a temporary reaction to rapid weight loss and reduced calorie intake, the same response seen after childbirth, major surgery, severe illness, or crash dieting. It typically starts two to three months after the trigger, and hair generally regrows once weight and nutrition stabilise.
Key takeaways
- The label reports hair loss in 3% at Wegovy 2.4 mg and 6% at 7.2 mg, against 1% on placebo.
- That dose-response points at the speed of weight loss as the trigger, not at the molecule.
- The two-to-three month delay means the shedding you see reflects an earlier stage.
- It is not usually a reason to stop — but other treatable causes look identical, which is why it is worth raising.
Important limitation: Trial adverse-event reporting captures what participants volunteered, not a dermatological assessment, and nobody counted hairs. The rates below establish that it happens more often than on placebo; they cannot tell you how severe it will be or how long it will last for any one person.
Next action: Ask your prescriber for iron, ferritin and thyroid testing before assuming it is the medication — those causes are treatable and present the same way. Protein intake is the one input you control: our diet guide sets a target.
Primary sources: DailyMed — FDA labels, StatPearls — telogen effluvium
General education, not medical advice.
What telogen effluvium actually is
Your hair follicles cycle between a growing phase and a resting phase. At any moment most follicles are growing. A significant physical stressor can push an unusually large share of them into the resting phase at once. Those hairs stay put for a couple of months, then shed together — which is why the shedding appears well after the event that caused it.
The characteristic experience is diffuse thinning across the whole scalp, and noticeably more hair in the shower drain, on the pillow, or in your brush. It does not usually produce bald patches or a receding hairline — those patterns point to different conditions worth getting checked.
Why GLP-1 treatment triggers it
The trigger is generally the weight loss itself, not a direct drug effect on hair:
- The speed of weight loss. The faster and larger the loss, the more likely the shedding.
- Eating substantially less. These medications work by reducing appetite, so intake of protein, iron, zinc, and other nutrients hair growth depends on often falls sharply — sometimes without the person noticing.
- The metabolic stress of a large energy deficit. The body deprioritises hair growth, which is not essential to survival.
This is why hair shedding is also well documented after bariatric surgery and other rapid weight-loss interventions — it tracks the weight loss, not the specific method.
What the label actually reports
Hair loss does appear in the Wegovy prescribing information as a reported adverse reaction, and the reported rate rises with dose:
| Group | Reported hair loss |
|---|---|
| Placebo | 1% |
| Wegovy 2.4 mg weekly | 3% |
| Wegovy 7.2 mg weekly | 6% |
Two things follow from those numbers. Hair loss is not one of the common side effects — at the standard 2.4 mg dose it was reported by roughly 3 in 100 people, against 1 in 100 on placebo. But the rate doubles again at the higher dose, which fits the pattern you would expect if the driver is the speed and scale of weight loss rather than a direct drug effect on the follicle.
What typically happens, and when
- Onset: commonly around two to three months after significant weight loss begins.
- Peak: shedding is usually heaviest over a period of weeks, then slows.
- Recovery: regrowth generally follows once weight and nutrition stabilise, though returning to full thickness takes months, because hair grows slowly.
What actually helps
- Prioritise protein. When you are eating much less overall, protein is the first thing to protect. This is worth planning deliberately rather than leaving to appetite.
- Ask about bloodwork. Iron and ferritin, thyroid function, and vitamin D are worth checking — deficiency and thyroid disease cause the same picture and are treatable.
- Consider the pace of weight loss. If loss is very rapid, your prescriber may discuss dose adjustments.
- Be gentle with your hair while shedding — avoid tight styles and harsh heat. This does not change the underlying cause, but avoids adding breakage.
- Be sceptical of supplements marketed for this. Supplementing a nutrient you are not short of does not help, and some — high-dose vitamin A and selenium — can cause hair loss themselves. Test first, then treat what you find.
Talk to a doctor if
- You have distinct bald patches, rather than diffuse thinning.
- Shedding continues well beyond six months, or worsens after weight stabilises.
- You also have fatigue, cold intolerance, or other symptoms suggesting thyroid disease or anaemia.
- There is scalp pain, scaling, redness, or scarring.
- It is affecting your wellbeing — that alone is a legitimate reason to seek help.
Should you stop the medication?
That is a decision for you and your prescriber, but hair shedding of this type is generally self-limiting and not a sign of harm, while the conditions being treated carry real risks of their own. Do not stop a prescribed medication on your own — raise it with your prescriber, who can also check for the treatable causes above. For related background, see how GLP-1 medications work and our full side-effect overview.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- StatPearls clinical referenceNCBI Bookshelf, U.S. National Library of MedicineSupports: Telogen effluvium: triggers, typical 2–3 month delay, and expected recovery.
- FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: Whether alopecia appears as a reported adverse reaction in each product's label.
- Patient drug and condition informationMedlinePlus, U.S. National Library of MedicineSupports: Patient-level background on hair-shedding causes and nutritional deficiency.
- Diabetes, obesity and digestive-disease informationNational Institute of Diabetes and Digestive and Kidney Diseases (NIH)Supports: Rapid weight loss and nutritional considerations during obesity treatment.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.